Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 11/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 9/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22491768 | 0.84 | SLC6A3 (0.37) | FFAR1SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL30207003 | 0.84 | SLC6A3 (0.37) | FFAR1SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL13278671 | 0.84 | SLC6A3 (0.37) | FFAR1SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL22491762 | 0.84 | FFAR1 (0.55) | FFAR1SLC6A3SLC6A2SLC6A4ALDH1A1 | |
| SCHEMBL14797824 | 0.84 | FFAR1 (0.55) | FFAR1SLC6A3SLC6A2SLC6A4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL22491794 | 0.83 | FFAR1 (0.54) | FFAR1SLC6A3SLC6A2SLC6A4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL22491792 | 0.83 | FFAR1 (0.54) | FFAR1SLC6A3SLC6A2SLC6A4ALDH1A1 | |
| SCHEMBL29802478 | 0.81 | L3MBTL1 (0.40) | SLC6A3SLC6A2SLC6A4ALDH1A1HPGD | |
| SCHEMBL23509591 | 0.81 | L3MBTL1 (0.40) | SLC6A3SLC6A2SLC6A4ALDH1A1HPGD | |
| SCHEMBL22491782 | 0.80 | L3MBTL1 (0.39) | SLC6A3SLC6A2SLC6A4ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332435-B2 | Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-05-17 | — | — | US | disclosed |
| US-20210179541-A1 | Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179541-A1 | Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient | FABP3, PCCA, HMGCR | FFAR1 108/4885SLC6A3 1802/4885SLC6A2 3025/4885 |
| US-11332435-B2 | Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient | FABP3, PCCA, HMGCR | FFAR1 108/4885SLC6A3 1802/4885SLC6A2 3025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.